2013-05-23@12:09:00 ET
Celgene Announces U.S. FDA Grants Priority Review for ABRAXANE(R) sNDA in Advanced Pancreatic Cancer (BIZ)
|
2013-05-23@12:03:00 ET
Celgene Announces U.S. FDA Grants Priority Review for ABRAXANE(R) sNDA in Advanced Pancreatic Cancer (BIZ)
|
2013-05-23@08:36:10 ET
Sector Update: Healthcare Shares Lower In Pre-Market; Celegene Sinks 1% Despite FDA's Priority Review (MID)
|
2013-05-23@08:34:52 ET
Sector Update: Healthcare (MID)
|
2013-05-23@07:36:01 ET
Celgene Announces U.S. FDA Grants Priority Review for ABRAXANE(R) sNDA in Advanced Pancreatic Cancer (BIZ)
|
2013-05-22@13:23:40 ET
Celgene (CELG) Approaches New Upside Target of $125.39 (F79)
|
2013-05-22@11:54:46 ET
Bullish Moving Average Cross by Celgene (CELG) (F78)
|
2013-05-22@11:00:06 ET
Buyers Accumulate Shares of Celgene, Up 3.7% (F77)
|
2013-05-21@08:26:23 ET
Celgene (CELG) Trading Near $120.99 Support Level (FBM)
|
2013-05-21@07:57:08 ET
Today's Research on CELG, ARNA, INCY, SPPI, and GERN (BSR)
|
2013-05-17@11:53:55 ET
WEALTHMAKERS.COM Issues Bullish Research Reports on ACIW, AEZS, ARCO, BODY, CELG, CLD (MTO)
|
2013-05-15@09:03:15 ET
Celgene (CELG) Showing Bullish Technicals With Resistance At $132.93 (FBM)
|
2013-05-13@15:00:10 ET
Shares of Celgene Rise Above Previous 52-Week High (F71)
|
2013-05-13@13:03:35 ET
Buyers Accumulate Shares of Celgene, Up 2.5% (F77)
|
2013-05-13@09:31:00 ET
Critical Alerts For Yahoo!, Celgene, Brinker International, Qlik Technologies, and Beam Released By InvestorsObserver (PRN)
|
